Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-27

FDA Approved: EPIDUO FORTE — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved a supplemental application for Epiduo Forte (adapalene and benzoyl peroxide) by Galderma Laboratories, L.P.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPIDUO FORTE (adapalene and benzoyl peroxide)

Snippet

SUPPL AP for EPIDUO FORTE (ADAPALENE AND BENZOYL PEROXIDE)